Intra-Cellular Therapies, Inc. Underwriting Agreements
8 Contracts & Agreements
- Underwriting Agreement, dated April 17, 2024, by and among the Company, J.P. Morgan Securities LLC, Leerink Partners LLC, BofA Securities, Inc., Morgan Stanley & Co. LLC and RBC... (Filed With SEC on April 18, 2024)
- Underwriting Agreement, dated January 4, 2022, by and among the Company, J.P. Morgan Securities LLC, SVB Leerink LLC, BofA Securities, Inc., Evercore Group L.L.C. and RBC Capital... (Filed With SEC on January 5, 2022)
- Underwriting Agreement, dated September 10, 2020, by and among the Company, J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC, and SVB Leerink LLC, as representatives of the... (Filed With SEC on September 11, 2020)
- Underwriting Agreement, dated January 7, 2020, by and among the Company, J.P. Morgan Securities LLC and SVB Leerink LLC, as representatives of the several underwriters named... (Filed With SEC on January 8, 2020)
- Underwriting Agreement, dated September 27, 2017, by and among the Company, J.P. Morgan Securities LLC and Leerink Partners LLC, as representatives of the several underwriters... (Filed With SEC on September 28, 2017)
- INTRA-CELLULAR THERAPIES, INC. 7,935,000 Shares of Common Stock (Including 1,035,000 Option Shares) Underwriting Agreement (Filed With SEC on September 23, 2015)
- INTRA-CELLULAR THERAPIES, INC. 5,462,500 Shares of Common Stock (Including 712,500 Option Shares) Underwriting Agreement (Filed With SEC on March 6, 2015)
- INTRA-CELLULAR THERAPIES, INC. Shares of Common Stock Underwriting Agreement (Filed With SEC on January 24, 2014)
